Biotechnology company PharmaZen raises USD14.0m from ADM Capital’s Cibus Fund
Christchurch biotechnology company PharmaZen has raised USD14.0 million from an international agri-technology fund to expand its operations amid surging global demand for its nutraceutical products. Its portfolio of ingredients covers joint, bone, muscle and digestive health, along with marine and bovine collagen and animal nutrition. Many of these value-add